vascular endothelial cells vecs (PromoCell)
PromoCell is a verified supplier 
PromoCell manufactures this product 
96
Structured Review
PromoCell
vascular endothelial cells vecs
Vascular Endothelial Cells Vecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 215 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+12271/Human+Aortic+Endothelial+Cells/pm41633199-53-3-18
Average 96 stars, based on 215 article reviews
Vascular Endothelial Cells Vecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 215 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+12271/Human+Aortic+Endothelial+Cells/pm41633199-53-3-18
Average 96 stars, based on 215 article reviews
vascular endothelial cells vecs - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Cell Culture:Article Title: Diabetes impacts endothelial Weibel-Palade body biogenesis and VWF secretion Article Snippet: .. HUVECs: Pooled Human Umbilical Vein Cells (HUVECs) (PromoCell) cultured in basal endothelial cell growth media with supplement pack (PromoCell) and antimycotic (Gibco) added forming endothelial growth medium (EGM-2). hAECS: Article Title: Neutrophil-Derived Oncostatin M Contributes to Endothelial Cell Dysfunction During Treponema denticola Interaction Article Snippet: .. Article Title: Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels. Article Snippet: Aims: Advanced glycation end products (AGEs), particularly AGE-modified albumin (AGE-BSA), have been implicated in vascular inflammation and endothelial dysfunction, while neutrophil extracellular traps (NETs) are known to aggravate endothelial injury.. Here, we investigated whether AGE-BSA directly promotes endothelial inflammatory and thrombotic activation, modulates neutrophil oxidative stress and NET formation, and may enhance NET-induced endothelial inflammation.. Materials, methods, and key findings: In human aortic and human umbilical vein endothelial cells, two different endotoxin-free AGE-BSA formulations did not or only minimally alter the expression or secretion of inflammatory (IL-6, IL-1β, CCL2) or thrombotic (VCAM-1, tissue factor) markers. |